| Literature DB >> 7585220 |
D J Grainger1, L Wakefield, H W Bethell, R W Farndale, J C Metcalfe.
Abstract
Transforming growth factor beta 1 (TGF-beta 1) is a platelet-derived cytokine involved in both normal wound healing and scarring. We show that human platelets contain two pools of latent TGF-beta 1, which constitute more than 95% of the total TGF-beta assayed in whole platelets. During clotting, one pool, the large latent TGF-beta complex consisting of latent TGF-beta binding protein (LTBP), the latency-associated peptide (LAP) and the 25-kD mature TGF-beta 1 dimer is released into the serum. A second pool, which contains LAP but not LTBP, is retained in the clot, but can be released by RGD peptide. When the clot is dissolved by plasmin this bound TGF-beta 1 is gradually activated and released. If similar mechanisms operate in vivo, the clot will act as a slow-release capsule of TGF-beta 1 activity during wound healing.Entities:
Mesh:
Substances:
Year: 1995 PMID: 7585220 DOI: 10.1038/nm0995-932
Source DB: PubMed Journal: Nat Med ISSN: 1078-8956 Impact factor: 53.440